The Life Sciences Entrepreneurship Development Program is an immersive and experiential training program created by an unprecedented collaboration between Montréal InVivo, the life sciences and health technology (LSHT) cluster, the Faculty of Pharmacy at Université de Montréal, and Concordia University’s John Molson Executive Centre.
IRICoR and Polytechnique are proud collaborators of the program and offer the modules Development in Oncology and Development in Innovative Medical Technologies to enhance the content.
Join other aspiring leaders in integrating novel management techniques in your innovative organization.
You will learn cutting-edge managerial techniques, providing you strategies to develop and grow an innovative business. Divided into ten intensive 2-day modules from February 2019 to January 2020, you will experience more than 150 hours of relevant strategic content. Designed to strengthen the skills of all LSHT innovative thinkers, you will be able to:
Apply leading management techniques from the lab to the market
Obtain valuable industry insights and tools to speed up the growth of your business
Stand out by bringing high-impact knowledge to your business
Management employees in the life sciences sector
Off-sector professionals dealing with life sciences (e.g. insurance, banking)
Life Sciences and Health Technologies (LSHT) Industry Overview
Pharmaceuticals and devices development isn’t a linear journey and operates more and more in a virtual environment where stakeholders’ roles change. To be successful in this field, you need to have a good understanding of the different challenges and opportunities stakeholders encounter. In this module, you will learn how different groups in the LSHT ecosystem relate to one another and what their roles and expectations are. Through real-life situations and case studies, you will look at the complete development cycle from discovery to market and witness how having the ability to rapidly map and connect key stakeholders to important milestones is a crucial part of producing a realistic development plan.
LSHT Market Access and Regulatory Environment
Understanding the market access and regulatory environments in the LSHT industry is key to successfully commercializing projects. Using real-life situations and case studies, this module explores the different challenges and perspective stakeholders encounter, as well as the strategic issues and market decisions that researchers and LSHT companies might consider at different stages to optimize business development.
Design Thinking Concepts—Part 1
This interactive module aims to give you a head start against your competitors by introducing you to the world of design thinking. This method focuses on solving problems by paying attention to the solution instead of the problem itself. Using design-thinking concepts such as rapid iterations, human-centred design, and collaboration and teamwork, you will learn and practise how to apply this strategy to your own ideas.
Design Thinking Concepts—Part 2
In this module, you will continue to delve into the world of design thinking which will allow you to understand the concepts on a deeper level in order to retrieve them more easily for use in the future.
Customers, Marketing, Public Relations, and Crisis Management: An LSHT perspective
In this module, you will gain an understanding about the biopharma ecosystem from commercialization to consumers. Using both case studies and real-life situations, you will explore important elements of marketing and clinical research such as the necessity of planning early, involving the key stakeholders, public relations, the need for a comprehensive plan, and risk management.
Business Model Canvas
You will create your own Business Model Canvas; a strategic management and lean startup template used to develop new business models or document existing ones. It is a visual chart with elements describing a firm or product’s value proposition, infrastructure, customers and finances. It assists firms in aligning their activities by illustrating potential trade-offs. This module will give you the tools and knowledge needed to validate your own business model using a Business Model Canvas.
Business Model Validation
The Business Model Validation includes carrying out discovery interviews with users, customers and business partners in order to ideate various hypotheses integrated into the Business Model Canvas through successive iterations. In this session, you will examine a case involving a District 3 startup, which will provide an isolated example in which to introduce concepts quickly.
Basics of Customer Relationship Management - Part 1
Customer Relationship Management (CRM) & Generating Sales are considered to be key sets of skills for all innovations as no innovation can go to market without interaction and trade with the organizations which animate this ecosystem. The module entails tools and skills to Generate Leads, Targeted Outreach, Manage Leads and Generate Sales. Provided tools are Funnel Mapping, Sales Dialogue, Negotiation, Ideal Customer Profile and the concepts of Pain Gain Claim communication tactics. Managing business relations requires skill sets on understanding Unit Economics, Financial Modelling, Dilution & Fundraising & Round Hacking.
Basics of Customer Relationship Management - Part 2
This module is a continuation of Basics of Customer Relationship Management - Part 1 (See above)
Product Market Fit
Product Market Fit is the go-to-market step that comes after the completion of a Business Model Validation sprint. This step will transform your business model into a repeatable, scalable and profitable business transaction. Navigating through the Ecosystem is provided through understanding Targets, TAM, SAM & Beachhead Market and tools such as SWOT analysis the ICE Framework and the Only Metric that Matters (OMTM) combined with an A/B plan for “Build, Measure, Learn” cycles. These management tools have been proven as the most effective and efficient for getting your product to the Product Market Fit phase.
Financing 101 Bootcamp — ONLINE (optional)
This module will act as an introduction to the core concepts of financial management and firm value maximization. Key concepts covered in this module will include valuing corporate securities, estimating cash flow, and making capital budget decisions. By the end of this module, you will understand conceptual frameworks underlying valuation and asset pricing and mechanics that determine the firm’s cost of capital.
Measuring and Reporting Financial Performance
The objective of this module is to ensure that you understand the relation between a company’s strategic decisions, business activities and financial statements. Using primarily case studies, we will focus on the different financing models in the LSHT industry and how risk is managed. We will also examine how boards of directors and investors can gauge the effectiveness of managerial stewardship in the creation of shareholder value.
Development in Oncology — In collaboration with IRICoR
Improved biological understanding in oncology has led to unprecedented therapeutic breakthroughs. In this module, we will focus on the exploration of new developments in drugs for cancer and entrepreneurial opportunities in cancer biology. We will discuss the challenges in drug development that the field experiences as well as highlight opportunities from the perspectives of different stakeholders. This session will help you understand the emerging trends in oncological drug development in order to foster an entrepreneurial mindset specific to the field.
Development in Innovative Medical Technologies
This module will provide you with a summary of the development of innovative medical technologies.
New Value Propositions Among LSHT Businesses
Innovation, cost and disruptive technologies have led to new LSHT business models that improve productivity, increase success rate and accelerate market access. This module will introduce:
new business models such as living labs, innovative manufacturing, virtual organization and open innovation
disruptive technologies like artificial intelligence, deep learning, big data, and 3D printing
emerging trends to introduce the innovation into the health care system.
We will examine the opportunities and challenges these concepts offer to use real-life situations and case studies.
By improving their command of the supply chain, companies deliver maximum value to the consumer while minimizing costs. This module covers the fundamental decisions and trade-offs related to the operations and supply chain management of a firm. We will examine strategic issues such as industry dynamics and competition, and the response firms might develop to handle such issues. You will also have the chance to explore some of the organizational, managerial, and other conditions required for firms to maximize their operational innovation.
Executive Presence—A Leadership Capability for the 21st century
As leaders, we can only affect and change things of which we are consciously aware. This is why the first step in building executive or managerial presence is to be self-aware. In order to succeed, leaders need to possess the curiosity to uncover blind spots and the vulnerability to openly seek feedback. This module focuses on the art of leadership—the language, models and frameworks that, when used appropriately, can create a positive impact on individuals, teams and organizations. We will hone in on building your skills in emotional intelligence in order to equip you with the attitudes and behaviours needed to forge higher quality relationships with customers and colleagues.
It is essential that you know how to deliver excellent pitches in various environments. This module will give you the tools needed to do just that. Core principles such as who, why, what, how and when will be explained, and will provide you with practical skills for delivering your pitch wherever you may be. You will practise these skills in a “Dragon’s Den” style simulation with judges, and will receive feedback from experienced coaches and from your peers.
Module 9 - Executive Presence – A Leadership Capability for the 21st century
December 13 & 14, 2019
Module 10 - Pitch Perfect
January 24 & 25, 2020
This program was developed with the funding of
Dates and fee
Dates: 2020 cohort — To be announced soon Format: Friday and Saturday — 10 modules — 20 days — 9 a.m. to 5 p.m. Location: John Molson School of Business, and Université de Montréal Language: Bilingual (French and English)* À la carte courses: $485 CAD (+applicable taxes) per day — See à la carte courses Academic researchers and students: $5,890 (+applicable taxes) — 25% discount Regular cost: $7,850 CAD (+applicable taxes)
Seats are limited. Complete payment is required to reserve a seat.
This program qualifies for the tuition tax credit (Federal T2202 and Provincial Relevé 8).
The program fee covers tuition and program materials. Lunches and refreshments for all morning and afternoon breaks are provided. Upon successful completion of the course, participants will receive a certificate signed by representatives from the John Molson Executive Centre – Concordia University, Montréal InVivo and the Université de Montréal.
REQUIREMENTS AND CONDITIONS
*PREREQUISITE - Participants must be fluent in both English and French.
By registering to the program, the participants commit to attending all in-class modules. If not, the academic director could apply financial penalties or decide on an eviction from the program.
The participants commit to taking an active part in group work sessions, even if the project they work on is not theirs.
Denis deBlois, PhD
Professor, Faculty of Pharmacy
Université de Montréal
Denis DeBlois is a professor of pharmacology at the Faculty of Pharmacy of Université de Montréal, where he teaches drug discovery and development. He is director of the Bachelor program on Biopharmaceutical Sciences and Head of the honour program on Drug discovery, development and evaluation at the PhD level. Dr. deBlois has published over 85 scientific publications and book chapters, mainly on the response to tissue injury. He has over 7 years of experience as a scientific consultant for the pharmaceutical industry in Canada and the USA and is an alumnus of the American Course on Drug Development and Regulatory Sciences (2010) from the University of California, San Francisco. He is co-director of the Research Group on Drug Discovery and Evaluation at Université de Montréal (GRUM) and board member of the Canadian Society of Pharmaceutical Sciences (CSPS). He is Chair of the Pharmaceutical Science World Congress to be held in Montreal in 2020 with the International Federation of Pharmacy (FIP).
Michelle Savoie, MBA, MPH, PhD, LL.M, IAS.S
Associate Professor, Faculty of Pharmacy
Université de Montréal
Michelle Savoie is an Associate Professor of Practical Training at the Faculty of Pharmacy, Université de Montréal and CEO, Consilio Manuque. Until July 2015, she was also CEO of Montréal InVivo.
Mrs. Savoie has over 25 years of experience in the life sciences and pharmaceutical sector. She has held strategic positions at Schering Canada, Eli Lilly Canada and Bristol-Myers Squibb and participated in several boards including those of the Quebec Network for Personalized Healthcare (PHC), Montréal InVivo and Personalized Medicine Partnership for Cancer. She currently participated on the NEOMED Institute’s and the International Congress on PHC’s boards as well as on the Fonds de solidarité FTQ—New Economy Investment Committee. She was actively involved in the creation of the Quebec Consortium for Drug Discovery, the Quebec PHC Strategy, NEOMED and the early phase clinical research initiatives.
A biochemist by training, she also completed an MBA, a Masters in Public Health, a PhD in biomedical sciences, a Masters in Law and Health policy and the Directors Education Program of the Institute of Corporate Directors.
Contact us if you wish to receive more information about this program.